Tasso is a fast-growing Seattle-based startup focused on delivering at-home diagnostic testing to those who need it most. We are growing our footprint with leading health systems, clinical research organizations, academic medical centers, and more who are looking to deliver clinical-grade, convenient diagnostic tests to their patients. Tasso was originally founded to find a better way to collect blood instead of a painful fingerstick or time-consuming venous draw. Since then, our products have been used in pharmaceutical clinical trials, by Olympians as part of a new virtual anti-doping program, and broadly by hospital systems across the US.
External link for Tasso, Inc.
1631 15th Ave W
Suite 105
Seattle, Washington 98119, US
If you will be at The World Vaccine Congress Europe next week, be sure to attend this Clinical Trials Track presentation by IQVIA Laboratories. #WVCEU
Join Cari Kessing, PhD at next week’s World Vaccine Congress Europe show. Cari will be presenting on Vaccine Correlation using Tasso, Inc. devices. Attendees will learn more about validating the use of self-collection of capillary blood samples with Tasso devices in assays used for Vaccines Clinical Trials. https://lnkd.in/eDBWUKgW
Congratulations to our CEO and Co-Founder Ben Casavant on being named Innovator of the Year by the Puget Sound Business Journal. Read more about this year's PSBJ Health Care Leadership Awards here: https://lnkd.in/dKHibTYs #healthcare #leadership #healthcareinnovation
Tasso surveyed over 600 patients about their healthcare perspectives, preferences, and experiences, revealing key insights about the blood collection status quo. Nearly four out of five patients report anxiety about phlebotomy, one in three have delayed a prescribed blood test. Read the press release and full white paper here: https://lnkd.in/exe52wmX #healthcare #patientcentric #diagnostics
Join Tasso CTO and Co-Founder Erwin Berthier today at Pharma & Patient USA 2024 for his presentation on driving patient engagement and high-quality data collection. Attend the talk at 4:10pm ET, Stage 2, or visit us in the exhibit hall any time. #REPATIENTUSA
The PharmaVoice 100 list recognizes inspirational, trailblazing industry leaders. Tasso is honored to announce that our CEO and Co-Founder Ben Casavant is part of this year's winning class. Read his profile here: https://lnkd.in/e75NkPdN #PV100 #PharmaVoice100 #PharmaLeaders
The Society for Clinical Research Sites (SCRS) Site Solutions Summit starts tomorrow and we are looking forward to a great conference. Visit us at booth 119 throughout the meeting to learn about our clinical research solutions. Bobby Virasingh Kristin Sutton #SCRS
Our CEO Ben Casavant recently spoke with Mendelspod about the future of patient-centric blood collection technology. Learn more in this week's podcast episode: https://lnkd.in/g3T7V-QK #patientcentric #clinicaltrials #healthcare
Tasso will be exhibiting at the Society for Clinical Research Sites (SCRS) Global Site Solutions Summit this month. Contact us today to schedule your private consultation: www.tassoinc.com/contact Bobby Virasingh Kristin Sutton #SiteSolutions #ClinicalTrials #ClinicalResearch
If you are at LSX World Congress USA, be sure to attend tomorrow's panel "Streamlining Clinical Trials for Patients & Clinicians Through Digital". Our CEO Ben Casavant will be sharing insights on patient engagement and more. #Clinicaltrials #Patientcentric #LSXUSA
Tasso has been named to Will Reed's Top 100 class of 2024, an award celebrating series A & B companies that champion company culture. See why Tasso made the list: https://lnkd.in/gNc7k4wz #WillReedsTop100